Shares of LifeVantage reached a 52-week high on Tuesday, driven by the company's impressive financial performance in the fourth quarter. The stock experienced a 14% surge, reaching $5.89 per share at 1:05 p.m. ET. Notably, the volume of shares traded during this period exceeded the stock's 65-day average volume, totaling 1.6 million shares.
During earlier trading, the stock even touched an impressive 52-week high of $7.44 per share.
In the after-hours announcement on Monday, LifeVantage, a prominent health and wellness company, revealed its fourth-quarter financials. The company reported earnings per share of 15 cents on a significant revenue of $54.2 million. This performance marks a substantial improvement compared to the previous year's fourth quarter, during which LifeVantage suffered a loss of 11 cents per share on a revenue of $50.9 million.
On an adjusted basis, the company reported even stronger results, with 17 cents in earnings per share for the fourth quarter, surpassing the previous year's performance of just 1 cent.
LifeVantage also shared its optimistic outlook for fiscal year 2024, expressing expectations to generate revenue ranging between $216 million and $226 million.
Canadian Stocks Soar Mid-Trading
HP Inc. Reports Mixed Financial Results
Related Articles
![Oil M&A in a Changing Landscape](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Oil M&A in a Changing Landscape
Oil mergers and acquisitions are making a comeback with smaller premiums. Industry experts anticipate more acquisitions, shifting focus towards shareholder retu...
![U.S. Stock Futures Decline as Meta Shares Pull Back](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
U.S. Stock Futures Decline as Meta Shares Pull Back
U.S. stock futures decline as shares in Meta pull back following their latest results, while bond yields remain near recent highs.
![Syensqo: A Standalone Entity Achieves a High Market Capitalization](https://www.signalsforex.net/img/0888b08e-b978-43c0-bdb4-4db1785eb1d5/news-article-3.jpeg?fm=jpg&q=80&fit=max&crop=1440%2C1080%2C240%2C0)
Syensqo: A Standalone Entity Achieves a High Market Capitalization
Belgian chemicals company, Syensqo, successfully spins out from Solvay and debuts as a standalone entity with a market capitalization of 9.53 billion euros.